# Pelashield vs Xeroform

> **NCT07734519** · PHASE4 · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Skin Graft

## Interventions

- **DEVICE:** Pelashield
- **DEVICE:** Xeroform

## Key facts

- **NCT ID:** NCT07734519
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734519, "Pelashield vs Xeroform". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07734519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*